Skip to main content
NCBI home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1994 May;1(3):361–363. doi: 10.1128/cdli.1.3.361-363.1994

Use of zidovudine in human immunodeficiency virus-induced hepatitis.

D L Wertheim 1, E Valderamma 1, V R Bonagura 1
PMCID: PMC368264  PMID: 7496978

Abstract

Hepatitis is a common complication of human immunodeficiency virus (HIV) disease in children. Often a distinct pathogen cannot be identified. Therefore, by exclusion, one must consider HIV the direct pathogen. Zidovudine (AZT) has not been used as a treatment for HIV-positive children with presumed HIV-induced hepatitis because of the potential of this medication to exacerbate preexisting hepatitis. We have used AZT to treat an 8-month-old female with severe HIV-induced hepatitis and have achieved complete remission with this regimen. For some HIV-positive children with HIV-induced hepatitis, AZT may be the drug of choice to resolve hepatic inflammation caused by this virus.

Full text

PDF
361

Images in this article

362Image
on p.362
363Image
on p.363

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach N., Theise N. D., Schaffner F. Hepatic histopathology in the acquired immunodeficiency syndrome. Semin Liver Dis. 1992 May;12(2):205–212. doi: 10.1055/s-2007-1007392. [DOI] [PubMed] [Google Scholar]
  2. Czapar C. A., Weldon-Linne C. M., Moore D. M., Rhone D. P. Peliosis hepatis in the acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1986 Jul;110(7):611–613. [PubMed] [Google Scholar]
  3. Dubin G., Braffman M. N. Zidovudine-induced hepatotoxicity. Ann Intern Med. 1989 Jan 1;110(1):85–86. doi: 10.7326/0003-4819-110-1-85. [DOI] [PubMed] [Google Scholar]
  4. Duffy L. F., Daum F., Kahn E., Teichberg S., Pahwa R., Fagin J., Kenigsberg K., Kaplan M., Fisher S. E., Pahwa S. Hepatitis in children with acquired immune deficiency syndrome. Histopathologic and immunocytologic features. Gastroenterology. 1986 Jan;90(1):173–181. doi: 10.1016/0016-5085(86)90090-9. [DOI] [PubMed] [Google Scholar]
  5. Glasgow B. J., Anders K., Layfield L. J., Steinsapir K. D., Gitnick G. L., Lewin K. J. Clinical and pathologic findings of the liver in the acquired immune deficiency syndrome (AIDS). Am J Clin Pathol. 1985 May;83(5):582–588. doi: 10.1093/ajcp/83.5.582. [DOI] [PubMed] [Google Scholar]
  6. Gordon S. C., Reddy K. R., Gould E. E., McFadden R., O'Brien C., De Medina M., Jeffers L. J., Schiff E. R. The spectrum of liver disease in the acquired immunodeficiency syndrome. J Hepatol. 1986;2(3):475–484. doi: 10.1016/s0168-8278(86)80059-9. [DOI] [PubMed] [Google Scholar]
  7. Gradon J. D., Chapnick E. K., Sepkowitz D. V. Zidovudine-induced hepatitis. J Intern Med. 1992 Mar;231(3):317–318. doi: 10.1111/j.1365-2796.1992.tb00542.x. [DOI] [PubMed] [Google Scholar]
  8. Housset C., Boucher O., Girard P. M., Leibowitch J., Saimot A. G., Bréchot C., Marche C. Immunohistochemical evidence for human immunodeficiency virus-1 infection of liver Kupffer cells. Hum Pathol. 1990 Apr;21(4):404–408. doi: 10.1016/0046-8177(90)90202-g. [DOI] [PubMed] [Google Scholar]
  9. Kahn S. A., Saltzman B. R., Klein R. S., Mahadevia P. S., Friedland G. H., Brandt L. J. Hepatic disorders in the acquired immune deficiency syndrome: a clinical and pathological study. Am J Gastroenterol. 1986 Dec;81(12):1145–1148. [PubMed] [Google Scholar]
  10. Lafon M. E., Kirn A. Human immunodeficiency virus infection of the liver. Semin Liver Dis. 1992 May;12(2):197–204. doi: 10.1055/s-2007-1007391. [DOI] [PubMed] [Google Scholar]
  11. Lebovics E., Thung S. N., Schaffner F., Radensky P. W. The liver in the acquired immunodeficiency syndrome: a clinical and histologic study. Hepatology. 1985 Mar-Apr;5(2):293–298. doi: 10.1002/hep.1840050224. [DOI] [PubMed] [Google Scholar]
  12. Nakanuma Y., Liew C. T., Peters R. L., Govindarajan S. Pathologic features of the liver in acquired immune deficiency syndrome (AIDS). Liver. 1986 Jun;6(3):158–166. doi: 10.1111/j.1600-0676.1986.tb00283.x. [DOI] [PubMed] [Google Scholar]
  13. Schneiderman D. J., Arenson D. M., Cello J. P., Margaretten W., Weber T. E. Hepatic disease in patients with the acquired immune deficiency syndrome (AIDS). Hepatology. 1987 Sep-Oct;7(5):925–930. doi: 10.1002/hep.1840070522. [DOI] [PubMed] [Google Scholar]
  14. Shriner K., Goetz M. B. Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine. Am J Med. 1992 Jul;93(1):94–96. doi: 10.1016/0002-9343(92)90687-7. [DOI] [PubMed] [Google Scholar]
  15. Welch K., Finkbeiner W., Alpers C. E., Blumenfeld W., Davis R. L., Smuckler E. A., Beckstead J. H. Autopsy findings in the acquired immune deficiency syndrome. JAMA. 1984 Sep 7;252(9):1152–1159. [PubMed] [Google Scholar]
  16. Wilfert C. M. HIV infection in maternal and pediatric patients. Hosp Pract (Off Ed) 1991 May 15;26(5):55-62, 65-7. doi: 10.1080/21548331.1991.11704173. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES